158 related articles for article (PubMed ID: 6104036)
1. Epidemiology of HBV-associated delta agent: geographical distribution of anti-delta and prevalence in polytransfused HBsAg carriers.
Rizzetto M; Purcell RH; Gerin JL
Lancet; 1980 Jun; 1(8180):1215-8. PubMed ID: 6104036
[TBL] [Abstract][Full Text] [Related]
2. Delta agent infection in acute hepatitis and chronic HBsAg carriers with and without liver disease.
Craxì A; Raimondo G; Longo G; Giannuoli G; De Pasquale R; Caltagirone M; Patti S; Squadrito G; Pagliaro L
Gut; 1984 Nov; 25(11):1288-90. PubMed ID: 6500367
[TBL] [Abstract][Full Text] [Related]
3. Multicentre study of prevalence of HBV-associated delta infection and liver disease in drug-addicts.
Raimondo G; Smedile A; Gallo L; Balbo A; Ponzetto A; Rizzetto M
Lancet; 1982 Jan; 1(8266):249-51. PubMed ID: 6120275
[TBL] [Abstract][Full Text] [Related]
4. Significance of delta agent infection in chronic hepatitis B virus infection: a study in British carriers.
Weller IV; Karayiannis P; Lok AS; Montano L; Bamber M; Thomas HC; Sherlock S
Gut; 1983 Nov; 24(11):1061-3. PubMed ID: 6629117
[TBL] [Abstract][Full Text] [Related]
5. Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses.
Perrillo RP; Chau KH; Overby LR; Decker RH
Gastroenterology; 1983 Jul; 85(1):163-7. PubMed ID: 6406288
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of delta agent infection in Arabia: geographical distribution and prevalence of anti-delta.
el-Hazmi MA; Ramia S
Vox Sang; 1986; 50(4):216-9. PubMed ID: 3487881
[TBL] [Abstract][Full Text] [Related]
7. Influence of delta infection on severity of hepatitis B.
Smedile A; Farci P; Verme G; Caredda F; Cargnel A; Caporaso N; Dentico P; Trepo C; Opolon P; Gimson A; Vergani D; Williams R; Rizzetto M
Lancet; 1982 Oct; 2(8305):945-7. PubMed ID: 6127458
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus-associated coinfection and superinfection with delta agent: indistinguishable disease with different outcome.
Caredda F; Rossi E; d'Arminio Monforte A; Zampini L; Re T; Meroni B; Moroni M
J Infect Dis; 1985 May; 151(5):925-8. PubMed ID: 3989325
[TBL] [Abstract][Full Text] [Related]
9. Infections with the hepatitis B virus associated delta agent in an isolated West-African community.
Goudsmit J; van der Waals F; Ponzetto A; Forzani B; Dobbelaar C
J Trop Med Hyg; 1984 Dec; 87(6):257-62. PubMed ID: 6534990
[TBL] [Abstract][Full Text] [Related]
10. Infection with the delta agent in chronic HBsAg carriers.
Smedile A; Dentico P; Zanetti A; Sagnelli E; Nordenfelt E; Actis GC; Rizzetto M
Gastroenterology; 1981 Dec; 81(6):992-7. PubMed ID: 7286594
[TBL] [Abstract][Full Text] [Related]
11. Presence of delta antigen in liver biopsies of HBsAg positive patients with chronic liver diseases living in the Naples area.
Picciotto L; Abrescia N; Ciampi R
Boll Soc Ital Biol Sper; 1983 Jan; 59(2):189-91. PubMed ID: 6860493
[TBL] [Abstract][Full Text] [Related]
12. Transmission of hepatitis B and hepatitis delta viruses in the households of chronic hepatitis B surface antigen carriers: a regression analysis of indicators of risk.
Craxì A; Tinè F; Vinci M; Almasio P; Cammà C; Garofalo G; Pagliaro L
Am J Epidemiol; 1991 Sep; 134(6):641-50. PubMed ID: 1951268
[TBL] [Abstract][Full Text] [Related]
13. Risk of post-transfusion infection with the hepatitis delta virus. A multicenter study.
Rosina F; Saracco G; Rizzetto M
N Engl J Med; 1985 Jun; 312(23):1488-91. PubMed ID: 3990749
[TBL] [Abstract][Full Text] [Related]
14. Delta hepatitis in inapparent carriers of hepatitis B surface antigen. A disease simulating acute hepatitis B progressive to chronicity.
Farci P; Smedile A; Lavarini C; Piantino P; Crivelli O; Caporaso N; Toti M; Bonino F; Rizzetto M
Gastroenterology; 1983 Sep; 85(3):669-73. PubMed ID: 6873613
[TBL] [Abstract][Full Text] [Related]
15. Incidence and significance of antibodies to delta antigen in hepatitis B virus infection.
Rizzetto M; Shih JW; Gocke DJ; Purcell RH; Verme G; Gerin JL
Lancet; 1979 Nov; 2(8150):986-90. PubMed ID: 91776
[TBL] [Abstract][Full Text] [Related]
16. Epidemiologic patterns of infection with the hepatitis B virus-associated delta agent in Italy.
Smedile A; Lavarini C; Farci P; Aricò S; Marinucci G; Dentico P; Giuliani G; Cargnel A; Del Vecchio Blanco C; Rizzetto M
Am J Epidemiol; 1983 Feb; 117(2):223-9. PubMed ID: 6829551
[TBL] [Abstract][Full Text] [Related]
17. [Superinfection with delta agent in chronic carriers of HBsAg in Spain. Clinical, epidemiologic and virologic characteristics].
Bas L; Carreño V; Porres JC; Mora I; Gutiez J; de Torres M; Hernández Guio C
Rev Clin Esp; 1984 Oct; 175(2):67-9. PubMed ID: 6522725
[No Abstract] [Full Text] [Related]
18. Delta hepatitis in Malaysia.
Sinniah M; Dimitrakakis M; Tan DS
Southeast Asian J Trop Med Public Health; 1986 Jun; 17(2):229-33. PubMed ID: 3787309
[TBL] [Abstract][Full Text] [Related]
19. [Hepatitis B and the delta agent].
Jilg W; Roggendorf M; Zoulek G; Schlipköter U; Deinhardt F
Fortschr Med; 1984 Feb; 102(6):119-21. PubMed ID: 6706267
[TBL] [Abstract][Full Text] [Related]
20. The delta agent in acute and chronic hepatitis B infection in Sweden.
Norkrans G; Hermodsson S; Iwarson S
Scand J Gastroenterol; 1983 Jul; 18(5):675-8. PubMed ID: 6675189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
